Literatura - Dizertační práce

1. ALAGUSUNDARAM, M.; CHENGAIAH, B.; GNANAPRAKASH, K.; RAMKANTH, S.; MADHUSUDHANA, C; DHACHINAMOORTHI, D. Nasal drug delivery system - an overview. International Journal of Research in Pharmaceutical Sciences. 2010,1(4), 454-465. ISSN 0975-7538.

2. ARGIOLAS, A.; MELIS, M.; GESSA, G. Intraventricular oxytoxin induces yawning and penile erection in rats. European Journal of Pharmacology. 1985, 117(3), 395–396. ISSN 0014-2999. DOI: 10.1016/0014-2999(85)90018-4

3. BEVANS, T.; DEERING-RICE, C.; STOCKMANN, C.; LIGHT, A.; REILLY, C.;

SAKATA, D. J. Inhaled Remifentanil in Rodents. Anesthesia and Analgesia. 2016, 122(6), 1831-1838. ISSN 0003-2999. DOI: 10.1213/ANE.0000000000001228 4. BHARADWAJ, V. N.; TZABAZIS, A. Z.; KLUKINOV, M.; MANERING, N. A.;

YEOMANS, D. C. Intranasal Administration for Pain: Oxytocin and Other Polypeptides.

Pharmaceutics. 2021, 13(7), 1088. ISSN 1999-4923. DOI:

10.3390/pharmaceutics13071088

Dostupné z https://www.biolib.cz/cz/taxon/id40775/

8. BLANCHER, M.; MAIGNAN, M.; CLAPÉ, C.; QUESADA, J.-L.; COLLOMB-

MURET, R.; ALBASINI, F.; AGERON, F.-X.; FEY, S.; WUYTS, A.; BANIHACHEMI, J.-J.; BERTRAND, B.; LEHMANN, A.; BOLLART, C.; DEBATY, G.; BRIOT, R.;

VIGLINO, D. Intranasal sufentanil versus intravenous morphine for acute severe trauma pain: A double-blind randomized non-inferiority study. PLoS Medicine. 2019, 16(7), e1002849. ISSN 1549-1277. DOI: 10.1371/journal.pmed.1002849

9. CORRIGAN, M.; WILSON, S. S.; HAMPTON, J. Safety and efficacy of intranasally administered medications in the emergency department and prehospital settings.

American Journal of Health-System Pharmacy. 2015, 72(18), 1544-1554. ISSN 1079- 2082. DOI: 10.2146/ajhp140630

10. COWEN, R.; STASIOWSKA, M. K.; LAYCOCK, H.; BANTEL, C. Assessing pain objectively: the use of physiological markers. Anaesthesia. 2015, 70(7), 828-847. ISSN 0003-2409. DOI: 10.1111/anae.13018

12. ČSN EN ISO 10993-10. Biologické hodnocení zdravotnických prostředků - Část 10:

Zkoušky na dráždivost a přecitlivělost oddáleného typu. Praha: Český normalizační institut, 2009.

13. DE JONG, T. R; NEUMANN, I. D. Oxytocin and Aggression. In: HURLEMANN, R.;

GRINEVICH, V., ed. Behavioral Pharmacology of Neuropeptides: Oxytocin. Springer, Cham, 2017, s. 175-192. Current Topics in Behavioral Neurosciences, vol 35. ISBN 978-3-319-63738-9. DOI: 10.1007/7854_2017_13

14. DEHGHAN, M. H.; GAIKWAD, V. M.; DANDGE, B. Nasal Absorption of Drugs – Barriers and Solutions. Research Journal of Pharmmacy and Technology. 2009, 2(4):634-642. ISSN 0974-3618.

15. DETYNIECKI, K.; VAN ESS, P. J.; SEQUEIRA, D. J.; WHELESS, J. W.; MENG, T.

C.; PULLMAN, W. E. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters-a randomized, double-blind, placebo- controlled trial. Epilepsia. 2019, 60(9), 1797-1808. ISSN 0013-9580. DOI:

10.1111/epi.15159

16. DRÁBKOVÁ, J. Nitrožilní anestetika. Klinická farmakologie a farmacie. 2019, 33(2), 15-19. ISSN 1212-7973. DOI: 10.36290/far.2019.010

17. DVORSKY, G. Oxytocin keeps committed men away from attractive women [online].

Gizmodo, 2012 [cit. 31.1.2023]. Dostupné z: https://gizmodo.com/oxytocin-keeps- committed-men-away-from-attractive-women-5960442

18. ECKSTEIN, M.; SCHEELE, D.; WEBER, K.; STOFFEL-WAGNER, B.; MAIER, W.;

HURLEMANN, R. Oxytocin facilitates the sensation of social stress. Human Brain Mapping. 2014, 35(9), 4741-4750. ISSN 1065-9471. DOI: 10.1002/hbm.22508 19. EGAN, T. D. Remifentanil pharmacokinetics and pharmacodynamics. A preliminary

appraisal. Clinical Pharmacokinetics. 1995, 29(2), 80-94. ISSN 0312-5963. DOI:

10.2165/00003088-199529020-00003

31.1.2023]. Dostupné z: https://www.ema.europa.eu/en/documents/product- information/dzuveo-epar-product-information_cs.pdf

21. FDA. FDA announces preliminary assessment that certain naloxone products have the potential to be safe and effective for over-the-counter use [online]. FDA, 2022 [cit.

31.1.2023]. Dostupné z: https://www.fda.gov/news-events/press-announcements/fda- announces-preliminary-assessment-certain-naloxone-products-have-potential-be-safe- and-effective

22. FDA. Having Naloxone on Hand Can Save a Life During an Opioid Overdose [online].

FDA, 2019 [cit. 31.1.2023]. Dostupné z: https://www.fda.gov/consumers/consumer- updates/having-naloxone-hand-can-save-life-during-opioid-overdose

23. FOSTER, D.; UPTON, R.; CHRISTRUP, L.; POPPER, L. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery. Annals of Pharmacotherapy. 2008, 42(10), 1380-1387. ISSN 1060-0280.

DOI 10.1345/aph.1L168

24. GABRHELÍK, T.; MÁLEK, J. 20. Opioidy v léčbě pooperační bolesti. In: KOZÁK, J.;

LEJČKO, J.; VRBA, I. a kol. Opioidy. Praha: Mladá Fronta, 2018, s. 247-266. ISBN 978-80-204-4550-6.

25. GJERSTAD, A. C. Is skin conductance a predictor of arousal, noxious stimuli and pain in the sedated and anaesthetized patient? Ann Christin Gjerstad, ©2012. Series of dissertations submitted to the Faculty of Medicine, University of Oslo No. 1249. ISBN 978-82-8264-177-7

26. GJERSTAD, A. C.; STORM, H.; HAGEN, R.; HUIKU, M.; QVIGSTAD, E.;

RAEDER, J. Comparison of skin conductance with entropy during intubation, tetanic stimulation and emergence from general anaesthesia. Acta Anaesthesiologica

Scandinavica. 2007, 51(1), 8-15. ISSN 0001-5172. DOI: 10.1111/j.1399- 6576.2006.01189.x

27. GOSSEN, A.; HAHN, A.; WESTPHAL, L.; PRINZ, S.; SCHULTZ, R. T.; GRUNDER, G.; SPRECKELMEYER, K. N. Oxytocin plasma concentrations after single intranasal oxytocin administration - a study in healthy men. Neuropeptides. 2012, 46(5), 211-215.

ISSN 0143-4179. DOI: 10.1016/j.npep.2012.07.001

28. GRIM, M.; NAŇKA, O.; HELEKAL, I. Atlas anatomie člověka II. Praha: Grada Publ., 2017. ISBN 978-80-0904-3.

29. GUZMAN, Y. F.; TRONSON, N. C.; SATO, K.; MESIC, I.; GUEDEA, A. L.;

NISHIMORI, K.; RADULOVIC, J. Role ofoxytocin receptors in modulation of fear by social memory. Psychopharmacology. 2014, 231(10), 2097-2105. ISSN 0033-3158.

DOI: 10.1007/s00213-013-3356-6

30. HANSEN, M.S.; MATHIESEN, O.; TRAUTNER, S.; DAHL, J. B. Intranasal fentanyl in the treatment of acute pain--a systematic review. Acta Anaesthesiologica

Scandinavica. 2012, 56(4), 407-419. ISSN 0001-5172. DOI: 10.1111/j.1399- 6576.2011.02613.x

31. HAYASHIDA, M.; FUKUNAGA, A.; FUKUDA, K.; SAKURAI, S.; MAMIYA, H.;

ICHINOHE, T.; KANEKO, Y.; HANAOKA, K. The characteristics of intravenous adenosine-induced antinociception in a rabbit model of acute nociceptive pain: a comparative study with remifentanil. Anesthesia and Analgesia. 2006, 103(4), 1004- 1010. ISSN 0003-2999. DOI: 10.1213/01.ane.0000237306.05730.ea

32. HEINRICH, M.; BAUMGARTNER, T.; KIRSCHBAUM, C.; EHLERT, U. Social support and oxytocin interact to suppress cortisol and subjective responses to

psychosocial stress. Biological Psychiatry. 2003, 54(12), 1389-1398. ISSN 0006-3223.

DOI: 10.1016/s0006-3223(03)00465-7

33. HESHMATI, F.; NOROOZINIA, H.; ABBASIVASH, R.; MAHOORI, A.; GHARAEE, H. Intranasal sufentanil for postoperative pain control in lower abdominal pediatric

surgery. Iranian Journal of Pharmacology and Therapeutics. 2006, 5(2), 131-133. ISSN 1735-2657.

31.1.2023]. Dostupné z: https://docplayer.cz/114257588-Skopolamin-v-historii- anesteziologie.html

35. HESS, L.; MÁLEK, J. Netradiční způsoby aplikace anestetik. Možnosti jejich využití v urgentní medicíně a medicíně katastrof. Praha: Karolinum, 2016. ISBN 978-80-246- 3450-0.

36. HESS, L.; MÁLEK, J.; KURZOVÁ, A., JAČEK, M.; MATĚJČKOVÁ, J.; VOTAVA, M. Conjunctival administration of buprenorphine in rabbits. Pain Practice. 2012, 12(S1), 19-20. ISSN 1530-7085.

37. HESS, L.; MÁLEK, J.; KURZOVÁ, A.; HRUBÝ, Z.; ŠTEIN, K. Nasal oxytocin as anxiolytic agent before stomatology treatment. European Journal of Anaesthesiology.

2014, 31(Suppl. 52), 146. ISSN 0265-0215.

38. HESS, L.; VOTAVA, M.; MÁLEK, J.; KURZOVÁ, A.; SLÍVA, J. Sedative effects of intranasal oxytocin in rabbits and rhesus monkeys. Physiological Research. 2016, 65(Suppl 4), S473-S480. ISSN 0862-8408. DOI: 10.33549/physiolres.933513 39. HUANG, H.; MICHETTI, C.; BUSNELLI, M.; MANAGO, F.; SANNINO, S.;

SCHEGGIA, D.; GIANCARDO, L.; SONA, D.; MURINO, V.; CHINI, B.;

SCATTONI, M. L.; PAPALEO, F. Chronic and acute intranasal oxytocin produce divergent social effects in mice. Neuropsychopharmacology. 2014, 39(5), 1102-1114.

ISSN 0893-133X. DOI: 10.1038/npp.2013.310

40. INTRANASAL.NET. Therapeutic Intranasal Drug Delivery: Needleless treatment options for medical problems [online]. intranasal.net, 1999 [cit. 31.1.2023]. Dostupné z:

http://www.intranasal.net/Home/default.htm

41. JAČEK, M.; MATĚJČKOVÁ, J.; MÁLEK, J.; HESS, L.; SAMCOVÁ, E.

Determination of midazolam in rabbit plasma by GC and LC following nasal and ocular administration. Journal of Separation Science. 2013, 36(20), 3366-3371. ISSN:1615- 9314. DOI: 10.1002/jssc.201300401

42. KABILAN, A. Pharmacological Role of Oxytocin – A Short Review. Journal of Pharmaceutical Scientces and Research. 2014, 6(4), 220-223. ISSN: 0975-1459.

43. KIME, P. Defense Department Approves Ketamine-Based Antidepressant for Some Patients [online]. Military.com, 2020 [cit. 31.1.2023]. Dostupné z:

https://www.military.com/daily-news/2020/04/17/defense-department-approves- ketamine-based-antidepressant-some-patients.html

44. KIMURA, T.; TANIZAWA, O.; MORI, K.; BROWNSTEIN, M. J.; OKAYAMA, H.

Structure and expression of a human oxytocin receptor. Nature. 1992, 356(6369), 526- 529. ISSN 0028-0836. DOI: 10.1038/356526a0

45. KNOBLOCH, H. S.; GRINEVICH, V. Evolution of oxytocin pathways in the brain of vertebrates. Frontiers in Behavioral Neuroscience. 2014, 8(February), 31. ISSN 1662- 5153. DOI: 10.3389/fnbeh.2014.00031

46. KNOBLOCH, H. S.; CHARLET, A.; HOFFMANN, L. C.; ELIAVA, M.; KHRULEV, S.; CETIN, A. H.; OSTEN, P.; SCHWARZ, M. K.; SEEBURG, P. H.; STOOP, R.;

GRINEVICH, V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron. 2012, 73(3), 553-566. ISSN 0896-6273. DOI:

10.1016/j.neuron.2011.11.030

47. KNOR, J.; MÁLEK, J. Farmakoterapie urgentních stavů: průvodce léčbou život ohrožujících stavů. 3. dopl. a rozšíř. vyd. Praha: Maxdorf, 2019. Moderní

farmakoterapie; Jessenius. ISBN 978-80-7345-595-8.

48. KOZÁK, J.; LEJČKO, J.; VRBA, I. a kol. Opioidy. Praha: Mladá Fronta, 2018. ISBN 978-80-204-4550-6.

49. KUNDRA, A.; HEARD, C.; GARDNER, T.; WANAMAKER, C.; CIAMBELLA, C.

Intranasal Remifentanil as an Adjunct to Oral Midazolam Sedation in Pediatric Dental Patients. Journal of Anesthesiology & Intensive Care Medicine. 2017, 3(4), 555618.

ISSN 2474-7653. DOI: 10.19080/JAICM.2017.03.555618

50. KURZOVÁ, A.; HESS, L.; SLÍVA, J.; MÁLEK, J. Can changes in skin impedance be used to monitor sedation after midazolam and during recovery from anesthesia?

Physiological Research. 2021, 70(2), 265-272. ISSN 0862-8408. DOI:

10.33549/physiolres.934621

51. LEE, M. R.; SHNITKO, T. A.; BLUE, S. W.; KAUCHER, A. V.; WINCHELL, A. J.;

ERIKSON, D. W.; GRANT, K. A.; LEGGIO, L. Labeled oxytocin administered via the intranasal route reaches the brain in rhesus macaques. Nature Communication. 2020, 11(1), 2783. ISSN 2041-1723. DOI: 10.1038/s41467-020-15942-1

52. LESLIE, E.; PITTMAN. E.; DREW, B.; WALRATH, B. Ketamine Use in Operation Enduring Freedom. Military Medicine. 2021, 186(7-8), e720-e725. ISSN 0026-4075.

DOI: 10.1093/milmed/usab117

53. LYNN, R. R.; GALINKIN, J. L. Naloxone dosage for opioid reversal: current evidence and clinical implications. Therapeutic Advances in Drug Safety. 2018, 9(1), 63-88.

ISSN 2042-0986. DOI: 10.1177/2042098617744161

54. MACDONALD, E.; DADDS, M. R.; BRENNAN, J. L.; WILLIAMS, K.; LEVY, F.;

CAUCHI, A. J. A review of safety, sideeffects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011, 36(8), 1114-1126. ISSN 0306-4530. DOI: 10.1016/j.psyneuen.2011.02.015

55. MACDONALD, K.; FEIFEL, D. Oxytocin's role in anxiety: a critical appraisal. Brain Research. 2014, 1580(September), 22-56. ISSN 0006-8993. DOI:

10.1016/j.brainres.2014.01.025

56. MÁLEK, J. Fentanyl – 60 let od syntézy, historie opioidních analgetik. Anesteziologie a intenzivní medicína. 2020, 31(5), 217-224. ISSN 1214-2158. DOI:

10.36290/aim.2020.047

57. MÁLEK, J.; ŠEVČÍK, P. a kol. Léčba pooperační bolesti. 4. přeprac. a dopl. vyd.

Praha: Maxdorf, 2021. ISBN 978-80-7345-696-2.

58. MANJUSHREE, R.; LAHIRI, A.; GHOSH, B. R.; LAHA, A.; HANDA, K. Intranasal fentanyl provides adequate postoperative analgesia in pediatric patients. Canadian Journal of Anaesthesia. 2002, 49(2), 190-193. ISSN 0832-610X. DOI:

10.1007/BF03020494

59. MARSH, A. A Brief History of the Lie Detector [online]. IEEE.org, 2019 [cit.

31.1.2023]. Dostupné z: https://spectrum.ieee.org/tech-history/heroic-failures/a-brief- historyof-the-lie-detector

60. MELIS, M. R.; ARGIOLAS, A. Oxytocin, Erectile Function and Sexual Behavior: Last Discoveries and Possible Advances. International Journal of Molecular Sciences. 2021, 22(19), 10376. ISSN 1422-0067. DOI: 10.3390/ijms221910376

61. MICHELSEN, L. G.; HUG-jr., C. C. The pharmacokinetics of remifentanil. Journal of Clinical Anesthesia. 1996, 8(8), 679-682. ISSN 0952-8180. DOI: 10.1016/s0952- 8180(96)00179-1

62. MION, M. From “Circe's Root” to “Spongia Soporifera”: The Role of the Mandrake as True Anesthetic of Ancient Times, Journal of Anesthesia History. 2017, 3(4), 128-133.

ISSN 2352-4529. DOI: 10.1016/j.janh.2017.11.004

63. MODI, M. E.; CONNOR-STROUD, F.; LANDGRAF, R.; YOUNG, L. J.; PARR, L. A.

Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques.

Psychoneuroendocrinology. 2014, 45(July), 49-57. ISSN 0306-4530. DOI:

10.1016/j.psyneuen.2014.02.011

64. MUIN, D. A.; WOLZT, M.; MARCULESCU, R.; SHEIKH REZAEI, S.; SALAMA, M.; FUCHS, C.; LUGER, A.; BRAGAGNA, E.; LITSCHAUER, B.; BAYERLE- EDER, M. Effect of long-term intranasal oxytocin on sexual dysfunction in

premenopausal and postmenopausal women: a randomized trial. Fertility and Sterility.

2015, 104(3), 715-23.e4. DOI: 10.1016/j.fertnstert.2015.06.010

65. MYVMC. Anatomy and physiology of the nasal cavity (inner nose) and mucosa [online]. myVMC, 2012 [cit. 31.1.2023]. Dostupné z:

https://www.myvmc.com/medical-centres/lungs-breathing/anatomy-and-physiology-of- the-nasal-cavity-inner-nose-and-mucosa/

66. NEUMANN, I. D.; MALOUMBY, R.; BEIDERBECK, D. I.; LUKAS, M.;

LANDGRAF, R. Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology. 2013, 38(10), 1985-1993.

ISSN 0008-6223. DOI: 10.1016/j.psyneuen.2013.03.003

67. OLIVEIRA, V. E. M.; LUKAS, M.; WOLF, H. N.; DURANTE, E.; LORENZ, A.;

MAYER, A. L.; BLUDAU, A.; BOSCH, O. J.; GRINEVICH, V.; EGGER, V.; DE JONG, T. R.; NEUMANN, I. D. Oxytocin and vasopressin within the ventral and dorsal lateral septum modulate aggression in female rats. Nature Communication. 2021, 12(1), 2900. ISSN 2041-1723. DOI: 10.1038/s41467-021-23064-5

68. PARR, L. A.; MODI, M.; SIEBERT, E.; YOUNG, L. J. Intranasal oxytocin selectively attenuates rhesus monkeys' attention to negative facial expressions.

Psychoneuroendocrinology. 2013, 38(9), 1748-1756. ISSN 0306-4530. DOI:

10.1016/j.psyneuen.2013.02.011

69. PENDOLINO, A. L.; LUND, V. J.; NARDELLO, E.; OTTAVIANO, G. The nasal cycle: a comprehensive review*. Rhinology. 2018, 1, 67-76. ISSN 589-5613. DOI:

10.4193/RHINOL/18.021

70. PRIORESCHI, P. Medieval anesthesia--the spongia somnifera. Medical Hypotheses.

2003, 61(2), 213-219, ISSN 0306-9877. DOI: 10.1016/s0306-9877(03)00113-0 71. PROMMER, E.; THOMPSON, L. Intranasal fentanyl for pain control: current status

with a focus on patient considerations. Patient Preference and Adherence. 2011, 5(March), 157-164. ISSN 1177-889X. DOI: 10.2147/PPA.S7665.

72. RASH, J. A.; AGUIRRE-CAMACHO, A.; CAMPBELL, T. S. Oxytocin and pain a systematic review and synthesis of findings. Clinical Journal of Pain. 2014, 30(5), 453- 462. ISSN 0749-8047. DOI: 10.1097/AJP.0b013e31829f57df

73. RING, R. H.; MALBERG, J. E.; POTESTIO, L.; PING, J.; BOIKESS, S.; LUO, B.;

SCHECHTER, L. E.; RIZZO, S.; RAHMAN, Z.; ROSENZWEIG-LIPSON, S.

Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology. 2006, 185(2), 218-225. ISSN 0033- 3158. DOI: 10.1007/s00213-005-0293-z

74. ROSS, A. K.; DAVIS, P. J.; DEAR, G. del, GINSBERG, B.; MCGOWAN, F. X.;

STILLER, R. D.; HENSON, L. G.; HUFFMAN, C.; MUIR, K. T. Pharmacokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesthesia and Analgesia. 2001, 93(6), 1393-1401. ISSN 0003-2999. DOI:

10.1097/00000539-200112000-00008

75. SHETTY, R. M.; BELLINI, A.; WIJAYATILAKE, D. S.; HAMILTON, M. A.; JAIN, R.; KARANTH, S.; NAMACHIVAYAM, A. BIS monitoring versus clinical assessment for sedation in mechanically ventilated adults in the intensive care unit and its impact on clinical outcomes and resource utilization. Cochrane Database of Systematic Reviews.

z: https://www.sukl.cz/modules/medication/download.php?file=SPC166715.pdf&type=

spc&as=calypsol-spc

Dostupné z:

https://www.sukl.cz/modules/medication/download.php?file=SPC185185.pdf&type=sp c&as=fentanyl-torrex-spc

Dostupné z: https://www.sukl.cz/modules/medication/download.php?file=

SPC19510.pdf&type=spc&as=midazolam-accord-spc

https://www.sukl.cz/modules/medication/download.php?file=SPC154065.pdf&type=sp c&as=naloxone-wzf-polfa-spc

https://www.sukl.cz/modules/medication/download.php?file=SPC165439.pdf&type=sp c&as=oxytocin-avmc-spc

https://www.sukl.cz/modules/medication/download.php?file=SPC190640.pdf&type=sp c&as=remifentanil-b-braun-spc

Dostupné

z: https://www.sukl.cz/modules/medication/download.php?file=SPC166249.pdf&type=

spc&as=sufentanil-torrex-spc

83. ŠLAPÁK, I; JANEČEK, D.; LAVIČKA, L. Klinická anatomie a fyziologie nosu. In:

Základy otorinolaryngologie a foniatrie pro studenty speciální pedagogiky [online].

Brno: Klinika dětské ORL Lékařské fakulty MU a Fakultní Nemocnice Brno, 2009 [cit.

31.1.2023]. Dostupné z:

https://is.muni.cz/elportal/estud/pedf/js09/orl/web/pages/2_1_klinicka_anatomie_a_fyzi ologie_nosu.html.

84. ŠTOURAČ, P.; HARAZIM, H.; KOSINOVÁ, M. Postavení remifentanilu v porodnické analgezii. Anesteziologie a intenzivní medicína. 2014, 25(4), 281-287. ISSN 1214-2158.

85. TANAKA, A.; FURUBAYASHI, T.; ARAI, M.; INOUE, D.; KIMURA, S.;

KIRIYAMA, A.; KUSAMORI, K.; KATSUMI, H.; YUTANI, R.; SAKANE, T.;

YAMAMOTO, A. Delivery of Oxytocin to the Brain for the Treatment of Autism Spectrum Disorder by Nasal Application. Molecular Pharmaceutics. 2018, 15(3), 1105- 1111. DOI: 10.1021/acs.molpharmaceut.7b00991

86. TELEFLEX. Intranasální rozprašovací aplikátor MAD Nasal* [online]. Teleflex inc.,

87. THAKKER, A., SHANBAG, P. A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures. Journal of Neurology. 2013, 260(2), 470-474. ISSN 0340-5354. DOI: 10.1007/s00415-012-6659-3

88. VERGHESE, S. T., HANNALLAH, R. S., BRENNAN, M., YARVITZ, J. L., HUMMER, K. A., PATEL, K. M., HE, J., MCCARTER, R. The effect of intranasal administration of remifentanil on intubating conditions and airway response after

sevoflurane induction of anesthesia in children. Anesthesia and Analgesia. 2008, 107(4), 1176-1181. ISSN 0003-2999. DOI: 10.1213/ane.0b013e3181838e95

89. WALDHERR, M.; NEUMANN, I. D. Centrally released oxytocin mediates mating- induced anxiolysis in male rats. Proceedings of the National Academy of Sciences of the United States of America. 2007, 104(42), 16681-16684. ISSN 0027-8424. DOI:

10.1073/pnas.0705860104

90. WIDACKI, J. Discoverers of the Galvanic Skin Response. European Polygraph. 2015, 9(4), 209-220. ISSN 2380-0550. DOI: 10.1515/ep2015-0008

91. WINTERHALTER, M.; MUNTE, S.; GERHARD, M.; DANZEISEN, O.; JUTTNER, T.; MONACA, E.; HOY, L.; RAHEMEYER, N.; KIENBAUM, P. Prospective study comparing skin impedance with EEG parameters during the induction of anaesthesia with fentanyl and etomidate. European Journal of Medical Research. 2010, 15(2), 47- 53. ISSN 0949-2321. DOI: 10.1186/2047-783X-15-2-47

92. WINTERHALTER, M.; MUNTE, S.; TASCHENBRECKER, P.; HECKER, H.;

WEILBACH, C.; OSTHAUS, A. W.; GROSS, M.; PIEPENBROCK, S.; RAHE- MEYER. N. Skin impedance correlates to sedation grade, plasma propofol

concentrations and bispectral index during a target-controlled infusion of propofol.

European Journal of Anaesthesiology. 2009, 26(7), 589-596. ISSN 0265-0215. DOI:

10.1097/EJA.0b013e328329b149

93. WINTERHALTER, M.; SCHILLER, J.; MUNTE, S.; BUND, M.; HOY, L.;

WEILBACH, C.; PIEPENBROCK, S.; RAHEMEYER, N. Prospective investigation into the influence of various stressors on skin impedance. Journal of Clinical

Monitoring and Computing. 2008, 22(1), 67-74. ISSN 1387-1307. DOI:

10.1007/s10877-007-9107-7

94. YEOMANS, D. C.; HANSON, L. R.; CARSON, D. S.; TUNSTALL, B. J.; LEE, M. R.;

TZABAZIS, A. Z.; JACOBS, D.; FREY, W. H. Nasal oxytocin for the treatment of psychiatric disorders and pain: achieving meaningful brain concentrations.

Translational Psychiatry. 2021, 11(1), 388. ISSN 2158-3188. DOI: 10.1038/s41398- 021-01511-7

95. YOON, S.; KIM, Y. K. The Role of the Oxytocin System in Anxiety Disorders. In:

KIM, Y. K., ed. Anxiety Disorders. Singapore: Springer, 2020, s. 103-120. Advances in Experimental Medicine and Biology, vol 1191. ISBN 978-981-32-9704-3. DOI:

10.1007/978-981-32-9705-0_7

96. ZHANG, H., LU, Y., WANG, L., LV, J., MA, Y., WANG, W., LI, G., LI, Y. Bispectral index monitoring of sedation depth during endoscopy: a meta-analysis with trial

sequential analysis of randomized controlled trials. Minerva Anestesiology. 2019, 85(4), 412-432. ISSN 0375-9393. DOI: 10.23736/S0375-9393.18.13227-5

97. ZORUMSKI, C. F.; IZUMI, Y.; MENNERICK, S. Ketamine: NMDA Receptors and Beyond. Journal of Neuroscience. 2016, 36(44), 11158–11164. ISSN 0270-6474. DOI:

10.1523/JNEUROSCI.1547-16.2016

No documento Dizertační práce (páginas 65-78)